US Stock MarketDetailed Quotes

COCP Cocrystal Pharma

Watchlist
  • 2.1498
  • +0.0298+1.41%
Trading Nov 27 12:19 ET
21.87MMarket Cap-1168P/E (TTM)

Cocrystal Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cocrystal Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Cocrystal Pharma Earnings Reports

  • Cocrystal Pharma | 8-K: Cocrystal Pharma Reports Third Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

    Nov 13 15:33 ET

  • Cocrystal Pharma | 10-Q: Q3 2024 Earnings Report

    Nov 13 08:32 ET

  • Cocrystal Pharma | 8-K: Cocrystal Pharma Reports Second Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

    Aug 14 08:19 ET

  • Cocrystal Pharma | 10-Q: Q2 2024 Earnings Report

    Aug 14 08:05 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 22, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data